LONDON (AP) – Irish health officials on Sunday recommended a temporary discontinuation of the AstraZeneca vaccine following reports of severe blood clots in Norway after vaccination.
Dr Ronan Glynn, Ireland’s deputy chief medical officer, said the recommendation came after the Norwegian Drug Agency reported four cases of blood clots in adults after receiving the AstraZeneca vaccine.
He said that although there was no definite link between the cases of the vaccine, Irish health officials were cautiously advising against stopping the spread of the vaccine. Authorities in Denmark, Norway and Iceland have taken similar precautionary measures.
The Netherlands resumed it late Sunday evening, cautioning to discontinue AstraZeneca vaccination for two weeks. The health ministry said the move was followed by six new reports in Denmark և Norway on blood clotting և lowering platelet counts in people under 50 years of age.
The Dutch Drug Bureau also stressed that there was no link between the cases and the “vaccines”.
The Ministry of Health said no cases had been reported in the Netherlands.
AstraZeneca said in a statement on Sunday that it “wants to express its confidence in the safety of the COVID-19 vaccine based on clear scientific evidence.”
“Public safety will always come first,” said the British-Swedish biopharmaceutical company, adding that “this issue is under scrutiny, but the available evidence does not support the cause of the vaccine.”
The company noted that a review of the safety data of more than 17 million people in the UK who received the AstraZeneca vaccine in the EU “did not indicate a high risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia in any age group, gender, group or group.” in the country. “
The World Health Organization, the EU’s regulator of drugs, has previously said that there is no link between an increased risk of stem clots.
Follow the AP epidemic coverage: